Press release

1 in 3 patients impacted: Nutricia calls for action on cancer-related malnutrition at ESPEN

Prague, Czech Republic– September 14, 2025

  • 1 in 3 patients with cancer report their treatment to be delayed or interrupted due to weight loss1.
  • Early initiation of medical nutrition is shown to support treatment outcomes2, yet the vast majority of patients who need it never get it3.
  • Nutricia joins the healthcare professional community at the ESPEN 2025 congress in a collaborative effort to advance cancer care.

At the 47th ESPEN Congress in Prague, Czech Republic, Nutricia joins the global healthcare community to spotlight the transformative potential of medical nutrition in cancer care.

One in three patients with cancer reports to experience treatment delays or interruptions due to weight loss1. Despite established guidelines to address weight loss from medical societies, like the European Society for Clinical Nutrition and

Metabolism (ESPEN) or the European Society For Medical Oncology (ESMO), implementation of nutritional screening and care remains inconsistent. This leaves many patients without access to essential nutritional interventions when they need it the most, leading to malnutrition.

Bridging the gap: Why nutrition matters in cancer care

Malnutrition, i.e., not getting enough nutrients to cover daily needs, is not merely a side effect of cancer. It is a driver of poorer treatment outcomes and quality of life, longer hospital stays, reduced treatment tolerance, and increased healthcare costs4.

Clinical evidence shows that science-based medical nutrition interventions in cancer can help address malnutrition and maintain weight and muscle mass, improve quality of life, increase tolerance to treatment, reduce complications, and shorten hospital stays5. In fact, 85% of patients report that medical nutrition supported them throughout treatment1. Yet, only one in three patients who need it receive it3, due to low understanding of the benefits of medical nutrition, lack of standardized protocols, and overstretched healthcare systems.

 

As Prof. Carla Prado stated at the Nutricia Satellite Symposium, which she chaired today at ESPEN in Prague:

It’s up to all of us in clinical practice and medical research to drive better outcomes through solutions we know exist and can help. Multidisciplinary teams are crucial to ensuring adequate nutritional care, including early access to medical nutrition. There is an increasing number of hospitals around the world that have successfully implemented nutritional pathways to the benefit of thousands of patients with cancer and healthcare systems at large.

- Dr. Carla Prado, University of Alberta, Canada

An evidence-based approach to better care

New research findings by Nutricia presented at ESPEN further build on the evidence of medical nutrition in supporting patient outcomes during cancer treatment, through a total of seven abstracts.

Among these, a large-scale, multi-center, multi-country clinical trial involved patients receiving chemo- and immunotherapy for colorectal and lung cancer. It showed that high-protein, omega-3-enriched oral nutritional supplements help meet patients’ nutritional needs effectively6.

These studies are part of Nutricia’s robust evidence generation platform, dedicated to understanding and ultimately better meeting the nutritional needs of patients with cancer.

For example, patients with cancer require up to twice as much protein as healthy individuals, yet less than half meet their protein needs7. With its Fortimel and Nutrison ranges, Nutricia supports patients who are malnourished due to their cancer, providing science-based medical nutrition that helps meet their nutritional needs, when normal food alone is not enough8.

 

Katrien Van Laere, SVP Research & Innovation, Chief Medical & Scientific Officer at Danone comments:

Medical nutrition should be an integral part of cancer care. We are committed to contributing to the future of cancer care, by conducting and supporting cutting edge clinical research across the globe and developing nutritional solutions offering a superior experience, ultimately with the aim to improve patient outcomes. As researchers and clinicians, we must continue to champion medical nutrition as an integral part of cancer care. Together, we can raise the standard of care.

- Katrien Van Laere, SVP Research & Innovation, Chief Medical & Scientific Officer at Danone

  1. Blanchard et al., Support Care Cancer. 2024;32(1):S434
  2. Bargetzi et al. 2021 Ann Oncol; 32(8):1025-1033; Orsso et al. 2024 Am J Clin Nutr;120(6):1311-1324; Caccialanza et al. 2022 Support Care Cancer; 30(11):9667-9679
  3. Planas et al. 2015 Support Care Cancer, 24, 429-435; Dijksterhuis et al. J Natl Compr Canc Netw 2021; 19(2):144-152; Blanchard et al.,Clin Nutr ESPEN. 2024;64P1012
  4. Cereda E, et al. Nutritional Radiother Oncol. 2018;126(1):81-88; Tan S, et al. Clin Nutr. 2021;40(1):47-53; Meng Q, et al. Clin Nutr. 2021;40(1):40-46. 6; Baldwin C, et al. J Natl Cancer Inst. 2012;104(5):371-85.
  5. Grupinska J, et al. Nutrients. 2021;13(10):3549; Cereda E, et al. Nutritional Radiother Oncol. 2018;126(1):81-88; Tan S, et al. Clin Nutr. 2021;40(1):47-53; Meng Q, et al.Clin Nutr. 2021;40(1):40-46 ; Baldwin C, et al. J Natl Cancer Inst. 2012;104(5):371-85.
  6. ESPEN25-LB-2822
  7. Prado S, et al. 2012 Can J Diet Pract. 73(4):e298-303; McCurdy B, et al. Nutrients. 2019;11(11):2473; Stobaus N, et al. Nutr Cancer. 2015;67(5):818.
  8. Fortimel and Nutrison products are foods for special medical purposes and must be used under medical supervision.

About Nutricia

Building on 125 years of research, innovation and care, Nutricia pioneers medical nutrition that helps enable life-changing and life-saving health outcomes, so that people can live their life to its fullest.

Nutricia supports healthy growth and development in early life and plays its part addressing some of the world’s biggest health challenges from birth through to old age. The Nutricia portfolio includes a wide range of nutritional solutions for pre-term birth, faltering growth, food allergy, rare metabolic diseases, age-related conditions and chronic disease, such as frailty, cancer, and stroke.

As part of Danone, Nutricia embraces the company’s long-standing mission of bringing health through food to as many people as possible. Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal and environment impact. Visit www.nutricia.com.

 

Contact

Danone Press Office
press@danone.com

Are you a healthcare professional or (carer of) a diagnosed patient?

The product information for this area of specialization is intended for healthcare professionals or (carers of) diagnosed patients only, as these products are for use under healthcare professional supervision.

Please click ‘Yes’ if you are a healthcare professional or (carer of) a diagnosed patient, or ‘No’ to be taken to a full list of our products.

The information on this page is intended for healthcare professionals only.

If you aren't a healthcare professional, you can visit the page with general information, by clicking 'I'm not a healthcare professional' below.

x